Impact of COVID-19 Pandemic on Performance of Gastrointestinal Endoscopy
Background/Aims: Non-time-sensitive gastrointestinal endoscopy was deferred because of the risk of exposure to coronavirus disease 2019 (COVID-19), but no population-based studies have quantified the adverse impact on gastrointestinal procedures. This study examined the impact of the COVID-19 pandemic on the performance of esophagogastroduodenoscopy (EGD), colonoscopy, ERCP, and abdominal ultrasonography (US) in South Korea.
Methods: This nationwide, population-based study compared the claim data of EGD, colonoscopy, ERCP, and abdominal US in 2020 and 2021 (COVID-19 era) with those in 2019 (before the COVID-19 era).
Results: During the first year (2020) of the COVID-19 pandemic, the annual claim data of EGD and colonoscopy were reduced by 6.3% and 6.9%, respectively, but those of ERCP and abdominal US were increased by 1.0% and 2.9%, compared to those in 2019. During the first surge (March and April 2020) of COVID-19, the monthly claim data of EGD, colonoscopy, ERCP, and abdominal US were reduced by 28.8%, 43.8%, 5.1%, and 21.6%, respectively, in March 2020, and also reduced by 17.2%, 32.8%, 4.4%, and 9.5%, respectively, in April 2020, compared to those in March and April 2019. During March and April 2020, the monthly claims of ERCP, compared with those in 2019, declined less significantly than those of EGD and colonoscopy (both p<0.001).
Conclusions: The claims of EGD and colonoscopy were reduced more significantly than those of ERCP and abdominal US during the COVID-19 pandemic because ERCPs are time-sensitive procedures and abdominal USs are non-aerosolized procedures.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
---|---|
Enthalten in: |
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi - 82(2023), 5 vom: 25. Nov., Seite 239-247 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kim, Youn Kyung [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 27.11.2023 Date Revised 21.12.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.4166/kjg.2023.102 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364884754 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364884754 | ||
003 | DE-627 | ||
005 | 20231227135409.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4166/kjg.2023.102 |2 doi | |
028 | 5 | 2 | |a pubmed24n1234.xml |
035 | |a (DE-627)NLM364884754 | ||
035 | |a (NLM)37997220 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kim, Youn Kyung |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of COVID-19 Pandemic on Performance of Gastrointestinal Endoscopy |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.11.2023 | ||
500 | |a Date Revised 21.12.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background/Aims: Non-time-sensitive gastrointestinal endoscopy was deferred because of the risk of exposure to coronavirus disease 2019 (COVID-19), but no population-based studies have quantified the adverse impact on gastrointestinal procedures. This study examined the impact of the COVID-19 pandemic on the performance of esophagogastroduodenoscopy (EGD), colonoscopy, ERCP, and abdominal ultrasonography (US) in South Korea | ||
520 | |a Methods: This nationwide, population-based study compared the claim data of EGD, colonoscopy, ERCP, and abdominal US in 2020 and 2021 (COVID-19 era) with those in 2019 (before the COVID-19 era) | ||
520 | |a Results: During the first year (2020) of the COVID-19 pandemic, the annual claim data of EGD and colonoscopy were reduced by 6.3% and 6.9%, respectively, but those of ERCP and abdominal US were increased by 1.0% and 2.9%, compared to those in 2019. During the first surge (March and April 2020) of COVID-19, the monthly claim data of EGD, colonoscopy, ERCP, and abdominal US were reduced by 28.8%, 43.8%, 5.1%, and 21.6%, respectively, in March 2020, and also reduced by 17.2%, 32.8%, 4.4%, and 9.5%, respectively, in April 2020, compared to those in March and April 2019. During March and April 2020, the monthly claims of ERCP, compared with those in 2019, declined less significantly than those of EGD and colonoscopy (both p<0.001) | ||
520 | |a Conclusions: The claims of EGD and colonoscopy were reduced more significantly than those of ERCP and abdominal US during the COVID-19 pandemic because ERCPs are time-sensitive procedures and abdominal USs are non-aerosolized procedures | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Colonoscopy | |
650 | 4 | |a ERCP | |
650 | 4 | |a Esophagogastroduodenoscopy | |
650 | 4 | |a Ultrasonography | |
700 | 1 | |a Park, Su Bee |e verfasserin |4 aut | |
700 | 1 | |a Lee, Moonhyung |e verfasserin |4 aut | |
700 | 1 | |a Youn, Jin Young |e verfasserin |4 aut | |
700 | 1 | |a Kwak, Min Seob |e verfasserin |4 aut | |
700 | 1 | |a Cha, Jae Myung |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi |d 2003 |g 82(2023), 5 vom: 25. Nov., Seite 239-247 |w (DE-627)NLM14272808X |x 2233-6869 |7 nnns |
773 | 1 | 8 | |g volume:82 |g year:2023 |g number:5 |g day:25 |g month:11 |g pages:239-247 |
856 | 4 | 0 | |u http://dx.doi.org/10.4166/kjg.2023.102 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 82 |j 2023 |e 5 |b 25 |c 11 |h 239-247 |